FDA Approved: YAZ — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Bayer’s supplemental application for YAZ (drospirenone and ethinyl estradiol), authorizing updates to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception
• Pregnancy Prevention

Drugs mentioned

• YAZ (DROSPIRENONE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for YAZ (DROSPIRENONE AND ETHINYL ESTRADIOL)